ArticleFrontiers in genetics2024

Pan-cancer analysis and experimental validation of FPR3 as a prognostic and immune infiltration-related biomarker for glioma.

Chenglin Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.